Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | EPD | ENB |
|---|---|---|
| Price | $37.50 | $47.47 |
| Change today | ▼ 0.20% | ▼ 0.80% |
| Market cap | $80.97B | $105.79B |
| Return, 3 months | +5.4% | -11.8% |
| Return, year to date | +22.4% | +7.5% |
| Return, 1 year | +25.9% | +6.4% |
| P/E (TTM) | 13.0 | 25.7 |
| P/B | 2.7 | 2.5 |
| P/E percentile vs own 5y | 90th | 75th |
| Dividend yield | 5.84% | 5.68% |
| Revenue growth (YoY, latest qtr) | +60.8% | +97.1% |
| Net profit growth (YoY) | +27.6% | -32.4% |
| Gross margin | 13.2% | 25.7% |
| Operating margin | 12.8% | 13.6% |
| Net margin | 10.7% | 6.8% |
| Return on equity | 21.0% | 9.7% |
| Analyst target vs. price | +11.7% | +21.4% |
| Analyst buy share | 40% | 57% |
| RSI (14) | 44 | 38 |
| 30-day volatility | 16.0% | 19.0% |
| Max drawdown, 1 year | -9.3% | -15.4% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.